ArticleRevista medica del Instituto Mexicano del Seguro Social2026
[Brown tumor due to hyperparathyroidism secondary to chronic kidney disease: A clinical case].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Brown tumors are aggressive and lethal due to their osteolytic capacity. They occur in 1.5 to 1.7% of patients with secondary hyperparathyroidism. The objective is to present the unusual case of an adolescent with stage V chronic kidney disease (CKD) who developed a brown tumor at the angle of the mandible due to secondary hyperparathyroidism. Clinical case: A 14-year-old female with stage V CKD of 4 months of evolution. She came to the consultation because 3 months earlier she had developed a tumor at the level of the lower left second molar which caused an increase in volume in the cheek and ipsilateral facial asymmetry, as well as occasional mild bleeding due to biting. The tumor was identified at the level of the aforementioned molar, measuring 3 cm in diameter, firm, non-mobile, and not painful to palpation; it also showed enlargement of the ipsilateral mandibular angle. Computed tomography of the mandibular angle showed a locally aggressive, solid lesion that expanded the cortex and eroded to extrude into soft tissue. A biopsy identified giant cell granuloma. Secondary hyperparathyroidism and subclinical hypothyroidism were detected; pharmacological management was initiated, with an adequate tumor's response. Conclusions: Brown tumors are very rare as the first clinical manifestation of secondary hyperparathyroidism in pediatric population. If a giant cell tumor is present in patients with CKD, brown tumor should be ruled out.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.